4540
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Tsumura & Co. is a pharmaceutical company specializing in the manufacturing and sale of Japanese medical and general-use medicines, with a focus on Kampo (traditional Chinese medicine) formulations. The company operates through a pharmaceutical segment that includes the cultivation, procurement, selection, processing, and storage of raw herbal ingredients. Key subsidiaries include Tsumura Co., Ltd. for core pharmaceutical operations, Logitem Tsumura for logistics and storage, and Yubari Tsumura for raw material processing. The group maintains a significant presence in China through entities such as Ping'an Tsumura, Shanghai Tsumura Pharmaceutical, and Tianjin Tsumura Pharmaceutical, which handle the manufacturing and sales of Kampo extract powders and herbal medicines. Additional operations in China involve raw material supply chains via Shenzhen Tsumura Pharmaceutical and Shengshi Baicao Pharmaceutical, as well as the production of herbal decoction pieces by Shanghai Hongqiao Chinese Medicine. The company also conducts raw material cultivation and processing in Laos through LAO TSUMURA CO., LTD. and engages in pharmaceutical development in the United States via TSUMURA USA, INC.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - Specialty & Generic Homepage tsumura.co.jp
Sector Healthcare IR page tsumura.co.jp
Tags
kampo medicine, herbal extracts, traditional chinese medicine, pharmaceutical manufacturing, raw material processing, logistics, herbal cultivation, Tsumura Co. Ltd., Logitem Tsumura, Yubari Tsumura, Ping'an Tsumura, Ping'an Tsumura Pharmaceutical, Shanghai Tsumura Pharmaceutical, Tianjin Tsumura Pharmaceutical, Shenzhen Tsumura Pharmaceutical, Shengshi Baicao Pharmaceutical, Bai Shan Lin Cun Chinese Medicine Development, Pingcun Zhongying (Hubei) Pharmaceutical, Pingcun (Shenzhen) Pharmaceutical, Shanghai Hongqiao Chinese Medicine, Ping'an Tsumura Chinese Medicine Technology, LAO TSUMURA CO. LTD., TSUMURA USA INC.
Press page tsumura.co.jp/news

Metrics

Valuation  
Market cap ¥ 291.452B
Market cap (USD) $ 1.822B
P/E 8.89
PEG 0.46
P/BV 0.74
P/S 1.41
P/OCF 8.99
P/FCF -54.96
Dividend yield 3.9%
Turnover / mcap —
Returns  
ROE 8.0%
ROI 6.2%
ROIC 5.7%
Profit margin 14.6%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 19.5%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 18
Quality score 16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 192.615B 181.093B 150.845B 140.043B 129.546B 130.883B 123.248B 120.906B 117.879B 114.954B 112.625B 110.438B 110.057B 105.638B
Net profit 28.117B 32.428B 16.707B 16.482B 18.836B 15.332B 13.765B 14.593B 14.504B 12.488B 12.557B 14.075B 18.05B 15.373B
Free cash flow -9.658B 4.029B -14.449B 1.744B 10.727B 6.686B 7.639B -3.491B 10.285B 12.766B 9.835B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.747K 4.315K 3.823K 2.631K 3.2K 3.956K 2.751K 3.365K 3.654K 3.49K 2.702K 2.971K 2.48K 3.474K
Price performance 12m -0.13 0.13 0.45 -0.18 -0.19 0.44 -0.18 -0.08 0.05 0.29 -0.09 0.2 -0.29 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 40.3B 42.9B 44.5B 47.2B 48.6B 110B 116B 134B 136B 144B
↳ YoY growth -3.6% +6.3% +3.8% +5.9% +3.1% +125.7% +5.8% +15.6% +1.3% +6.2%
↳ 5y CAGR +3.0% +22.2% +22.0% +24.7% +23.6% +24.3%
Borrowings, current (JPY) 12.6B 25.3B 10.3B 22.9B 22.9B 10.3B 10.3B 25.3B 5.29B 12.7B
Borrowings, non-current (JPY) 24.4B 39.4B 39.4B 42.4B 30B 39.4B 69.4B 54.4B 65.1B 122B
Bonds payable (JPY) — 30B 30B 30B 30B 30B 60B 60B 45B 45B
Cash and deposits (JPY) 29.9B 83.5B 72.2B 62B 61.3B 67.6B 94.8B 78.1B 73.2B 84.1B
Intangible assets (JPY) 266M 526M 872M 13.3B 11.4B 12.3B 14.6B 17.3B 18.2B 50.4B
Net debt (borrowings + leases - cash) (JPY) 7.03B -18.8B -22.6B 3.31B -8.46B -17.9B -15.1B 1.62B -2.89B 51.1B
Cash flow detail
Operating cash flow (JPY) 21.1B 21.1B 5.45B 18.2B 16.1B 21.3B 16.5B 5.61B 33.8B 24.7B
Purchases of property, plant and equipment (JPY) -8.21B -10.5B -8.51B -10B -8.95B -10.2B -12.2B -16.8B -27.6B -32.8B
Purchases of intangible assets (JPY) -88M -318M -427M -545M -467M -413M -2.48B -3.23B -2.2B -1.6B
Change in receivables (cash effect) (JPY) 1.47B -2.53B -1.68B -866M -1.41B -5.52B -2.94B -8.41B 434M 6.11B
Change in inventories (cash effect) (JPY) -1.12B 2.57B -2.65B -3.93B -4.52B -5.5B -5.96B -12.9B -9.65B -20.5B
Change in payables (cash effect) (JPY) 1.26B -1.3B 915M 134M -1.61B 3.79B 2.15B 2.65B 2.92B 2.25B
Dividends paid (cash effect) (JPY) -4.48B -4.4B -4.89B -4.9B -4.9B -4.9B -4.9B -5.13B -9.02B -10.3B
Share buybacks (cash effect) (JPY) -5B -1M — — — -3M -446M -1.32B -912M -6.13B
Interest paid (cash effect) (JPY) -142M -161M -163M -141M -275M -209M -232M -334M -529M -1.05B
Income taxes paid (cash effect) (JPY) -5.44B -3.88B -6.01B -4.14B -5.78B -7.07B -6.13B -6.38B -5.94B -12.6B
Operating cash flow before change in receivables (JPY) 19.6B 23.6B 7.13B 19.1B 17.5B 26.8B 19.4B 14B 33.4B 18.6B
Free cash flow (OCF - PPE - intangibles) (JPY) 12.8B 10.3B -3.49B 7.64B 6.69B 10.7B 1.74B -14.4B 4.03B -9.66B
Income detail
Research and development expense (JPY) 6.09B 6.05B 5.93B 6.27B 6.63B 7.31B 7.59B 8.29B 8.36B 8.48B
↳ 5y CAGR +2.1% +3.7% +4.7% +6.9% +5.9% +5.1%
Total comprehensive income (JPY) 11.3B 16.3B 13.1B 8.42B 17.4B 29.9B 19.8B 27.4B 45.1B 40.5B
Comprehensive income to owners (JPY) 11.4B 15.9B 13.1B 8.3B 17.6B 26.9B 17.8B 25.2B 39.6B 36.7B
Provision for credit losses (JPY) 0.00 0.00 0.00 0.00 0.00 62M 59M 129M — 57M
Credit cost ratio (credit losses / average receivables) (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% — 0.0%
Reported Jun 29, 2017 Jun 28, 2018 Jun 27, 2019 Jun 26, 2020 Jun 29, 2021 Jun 29, 2023 Jun 29, 2023 Jun 27, 2024 Jun 24, 2025 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Tsumura & Co. (ticker 4540), listed in Japan.

ETFs Holding Tsumura & Co.

ETF Weight in ETF Shares Market value As of
DISV 0.13% 265,600 $ 6.501M Nov 12, 2026
DFIS 0.07% 155,200 $ 3.799M Nov 12, 2026
AVDS 0.06% 8,200 $ 204.671K Nov 16, 2026
DFIC 0.02% 105,600 $ 2.585M Nov 12, 2026
DXIV 0.01% 1,200 $ 29.373K Nov 12, 2026
DFAX 0.01% 54,800 $ 1.341M Nov 12, 2026
AVDE 0.01% 40,700 $ 1.016M Nov 16, 2026
DFAI 0.01% 42,610 $ 1.043M Nov 12, 2026